Login / Signup

Evaluation of Patients with Fibrotic Interstitial Lung Disease: Preliminary results from the Turk-UIP Study.

Musellim BenanMogulkoc NesrinUzun OguzTokgoz Akyil FatmaTurktas HalukOzdemir Kumbasar OzlemOkumus GulferOgus CandanDirol HulyaZamani AdilSevim TulinAnnakkaya Ali NihatOzyurek Berna AkinciHanta IsmailAydemir YusufCakir Edis EbruKurt BaharTertemiz Kemal CanTabak LeventYazici OnurErdogan YurdanurAtes GungorTurker HaticeSalepci BanuHazar ArmaganNiksarlioglu Elif YeldaYılmaz Kara BilgeKokturk NurdanKalpaklioglu FusunUzel IsilOzsu SavasAtahan ErsanFendoglu Turkan ZeynepYilmaz SureyyaBasyigit IlknurCamsari GungorTuncay EsinUcar Yilmazel ElifKanmaz DilekEkici AydanurTopcu FusunUzaslan EsraBozkus FulsenArgun Baris SerapDuru SerapAltinisik GokselBingol ZuleyhaTunaci AtadanSavas RecepAlper FatihBayraktaroglu SelenSelcuk Can TubaDemir Ali Arslan
Published in: Turkish thoracic journal (2021)
The rate of IPF among patients with fibrotic ILD was 50%. In the differential diagnosis of IPF, sex, smoking habits, and the presence of clubbing are important. The presence of symptoms related to CTD, ESR elevation, and FANA positivity reduce the likelihood of IPF.
Keyphrases
  • idiopathic pulmonary fibrosis
  • interstitial lung disease
  • systemic sclerosis
  • smoking cessation
  • estrogen receptor
  • sleep quality